Cassava Sciences Announces Initiation of an Open-Label Study to Evaluate PTI-125 in Patients with Alzheimer’s Disease

NEXT STORY
Children’s Hospital of Georgia uses Philips’ automated early detection and warning solution to improve pediatric patient deterioration response
PREV STORY
Physician-led Online Healthcare Technology Company Applies for Novel Clinical Trial for COVID-19 Using Medical Cannabis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Plus Therapeutics to Present ReSPECT™-GBM Clinical Trial Data at the 2021 SNO Annual Meeting

author_avatar
NASDAQ Market News

XORTX Announces PKD Foundation Collaboration

author_avatar
NASDAQ Market News

Sun BioPharma, Inc. Provides a Business Update and Files Report for Q2 2018

First Patients Enrolled in Front-Line Combination Study of SBP-101 with Gemcitabine and nab-Paclitaxel for ...

author_avatar
NASDAQ Market News